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Abstract 
The link between immunity and metabolism in adipose tissue also extends to the 
complement system. Recent studies demonstrate complement receptor C5aR heterodimerization 
with C5L2, which we propose as a receptor for both complement C5a and acylation stimulating 
protein (ASP/C3adesArg), a lipogenic adipokine. The present study evaluates the C5aR 
contribution to regulation of adipocyte lipid metabolism, immune responses and signaling 
induced by C5a and/or ASP. 
The effects of C5a, ASP, and insulin on cytokine production, triglyceride synthesis 
(TGS), and signaling pathways in isolated primary adipocytes and cultured 3T3-L1 differentiated 
adipocytes were evaluated. In addition, mRNA expression of IRS1 and PGC1α was compared in 
adipose tissue samples from WT versus C5aRKO mice. 
Both ASP and C5a directly increased MCP1 and KC secretion, TGS, and Akt/NFκB 
phosphorylation pathways in adipocytes. However C5a effects were absent in C5aRKO 
adipocytes, while ASP effects were mostly maintained. Addition of C5a completely blocked 
ASP signaling and activity in both C5aRKO and WT adipocytes.  C5a also blocked effects of 
ASP in 3T3-L1 adipocytes. Furthermore, C5aRKO adipocytes revealed impaired insulin 
stimulation of cytokine production, with partial impairment of signaling and TGS stimulation, 
consistent with decreased IRS1 and PGC1α mRNA expression in adipose tissue. 
These observations are consistent with roles for C5aR in both metabolism and immunity 
in adipose tissue, which may be regulated through heterodimerization with C5L2.  
WORD COUNT = 220 
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1. Introduction
1
 
It is now well accepted that adipocytes play a dynamic role in metabolic regulation, with 
active synthesis and secretion of cytokines, adipokines, complement proteins, and molecules 
associated with inflammation (MacLaren R et al. 2008). Investigations have revealed major 
contributions of adipocytes to immunity, with adipocytes interacting and signaling with immune 
cells, including both resident and infiltrating macrophages, within the microenvironment of 
adipose tissue (Klos A et al. 2009, Poursharifi P et al. 2013, Tom FQ et al. 2013). Recently, 
complement protein/receptor interactions with adipokines have attracted attention, with 
“immunometabolism” being the subject of a number of reviews (MacLaren R et al. 2008, 
Nikolajczyk BS et al. 2012, Schâffler A and Schôlmerich J 2010, Schipper HS et al. 2012).  
Many inflammatory responses in the immune system are related to the complement 
cleavage fragments, C3a and C5a, known as anaphylatoxins (Klos A et al. 2009). These proteins 
mediate their signaling activities through several serpentine 7-transmembrane G protein-coupled 
receptors (GPCRs), which are expressed by various immune as well as non-immune cells (Klos 
A et al. 2009). C5a is regarded as one of the most potent inflammatory factors known, and 
functions via its receptor C5aR, but also binds C5aR-like receptor 2 (C5L2) (Cui W et al. 2009b, 
DeMartino JA et al. 1994, Ohno M et al. 2000, Okinaga S et al. 2003). Both C5L2 and C5aR are 
expressed on myeloid and non-myeloid cells such as adipocytes and preadipocytes, although 
C5aR mRNA levels are typically higher than C5L2 (Bamberg CE et al. 2010, Chen NJ et al. 
2007, Ohno M et al. 2000). As previously shown, phosphorylation of C5aR and C5L2 leads to 
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 Abbreviations: ASP, acylation stimulating protein; C5L2, C5aR-like receptor 2; GPCR, G protein-coupled 
receptor; TGS, triglyceride synthesis 
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association with β-arrestin proteins and internalization into clathrin-coated vesicles (Bamberg CE 
et al. 2010, Braun L et al. 2003, Cui W et al. 2009b). Notably, the complex array of C5a 
functional activities, including chemotaxis, enzyme/cytokine release, and the respiratory burst, 
are mostly attributed to its binding to C5aR (Okinaga S et al. 2003), with stimulation of MAPK, 
ERK, diacylglycerol and Akt signaling pathways (Monk PN et al. 2007, Ward PA 2009). While 
C5a binds C5L2 with the same high affinity as C5aR, the potential functions and signaling 
pathways mediated through C5L2 are still controversial (Cain SA and Monk PN 2002, Okinaga 
S et al. 2003).  
C3a and acylation stimulating protein (ASP/C3adesArg) both stimulate triglyceride 
synthesis (TGS) and glucose transport in adipocytes (Cianflone KM et al. 1989, Kalant D et al. 
2005). Adipocytes produce C3, factor B, and adipsin, leading to production of ASP within the 
adipocyte microenvironment upon activation of the alternative complement pathway (Baldo A et 
al. 1993). ASP induces Akt, MAPK, ERK1, and NFκb signaling pathways in 3T3-L1 adipocytes 
and/or preadipocytes (Maslowska M et al. 2006, Poursharifi P et al. 2013, Tom FQ et al. 2013). 
Tom et al. demonstrated ASP stimulation of monocyte chemoattractant protein (MCP)-1 and 
keratinocyte chemoattractant (KC) production in adipocytes, an effect blocked with PI3-kinase 
and NFκB inhibitors (Tom FQ et al. 2013). Further, complement C3 knockout mice, which are 
deficient in C3, the precursor of ASP, and therefore obligately deficient in ASP, demonstrate 
altered energy metabolism and fat storage (Paglialunga S et al. 2008, Roy C et al. 2008).  
The two receptors, C5aR and C5L2, have been proposed to have closely linked physical 
and functional interactions (Bamberg CE et al. 2010, Poursharifi P et al. 2013). Likewise, it has 
been demonstrated that C5aR and C5L2 are both capable of forming homo- and heterodimers 
(Poursharifi P et al. 2013). Interestingly, both ASP and C5a have been found to stimulate 
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internalization/colocalization of C5aR and C5L2 in J774 macrophages and 3T3-L1 adipocytes 
(Poursharifi P et al. 2013). The consequences of homo- or heterodimerization are not yet clear, 
however this could be linked to alternative signaling or regulatory cell- and ligand-dependent 
responses to severe inflammatory conditions or metabolic modulations. Further, the distinctive 
roles of C5aR and C5L2 in immunity and adipocyte metabolism are presently clouded by 
controversy. The aim of the current study was to investigate C5a-C5aR functions and signaling 
pathways and their possible regulatory effects on ASP/C5a signaling pathways in adipocytes 
using C5aR knockout (C5aRKO) mice and in vitro studies. 
7 
2. Methods 
2.1. Materials  
All tissue culture reagents, including Dulbeccos's modified Eagle's medium/F-12 
(DMEM/F12), phosphate buffered saline (PBS), fetal bovine serum (FBS), trypsin and tissue 
culture supplies were from Gibco (Burlington, ON). Triglyceride (TG) mass was measured using 
an enzymatic colorimetric assay (Roche Diagnostic, Indianapolis, IN). Recombinant ASP (rASP) 
was prepared as previously described in detail (Cui W et al. 2009a), and assessed for purity by 
mass spectrometry (Cui W et al. 2009a, Murray I et al. 1997), and was verified to be endotoxin-
free. Recombinant C5a (rC5a) (purity≥95% by SDS-PAGE) was purchased from EMD 
Biosciences (Gibbstown, NJ). Physiological concentrations of C5a (20 nM) and ASP (100 nM) 
were used in all of the experiments. 
2.2. Cell Culture of 3T3-L1 Preadipocytes and Differentiation into Mature Adipocytes 
 3T3-L1 preadipocytes, obtained from the American Type Culture Collection (Manassas, 
VA), were maintained in DMEM/F12 supplemented with 10% (v/v) fetal bovine serum (FBS) at 
37°C in 5% CO2. Differentiation was induced two days post confluence in medium containing 10 
μg/ml insulin, 1.0 μM dexamethasone, and 500 μM isobutylmethylxanthine (IBMX). After three 
days, the differentiation cocktail was replaced with insulin supplementation for 2 more days, 
then changed to 10% FBS in DMEM/F12 only. Media was changed on fully differentiated 3T3-
L1 adipocytes (≥80% differentiated as determined by microscopic evaluation of multiple lipid 
droplets) every two days and were used for functional and signaling assays on days 9-10 after 
differentiation was initiated. Throughout all experiments, cells were transferred to serum free 
(SF) medium 2 h prior to the treatments. 
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2.3. Mice  
BALB/c mice and C5aRKO mice on a BALB/c background were obtained from Jackson 
Laboratory (Bar Harbor, ME). Mice were housed in a sterile barrier facility with a 12 h light: 12 h dark 
cycle. All protocols were pre-approved by the Laval University Animal
 
Care Committee and 
were conducted in accordance
 
with the Canadian Council of Animal Care (CACC) guidelines. 
Animals were fed a standard chow diet ad libitum. 
2.4. Isolation and Culture of Primary Mouse Adipocytes  
Mice were euthanized and gonadal fat pads from wild type (WT) and C5aRKO (n=9-11 
in each group) were collected in Krebs-Ringer buffer (KRB), pH 7.4.  The tissue was minced and 
incubated in KRB buffer containing collagenase (collagenase type II, 0.1% (w/v)) at 37 °C for 45 
min. The resulting suspension was filtered through a nylon mesh (250 μm) and separated into 
two parts (floating mature adipocytes and pelleting stromal cells) by low-speed centrifugation. 
The mature adipocyte fraction was rinsed three times with KRB buffer, and adipocytes were 
counted and aliquoted for the various experiments of the study. 
2.5. Fluorescent Fatty Acid Uptake into Mature Adipocytes  
Uptake and incorporation into lipids of fluorescently-labeled fatty acid was measured 
using the QBT™ fatty acid uptake assay kit (Molecular Devices, Sunnyvale, CA) in 3T3-L1 
adipocytes and primary adipocytes, according to the manufacturer's instructions. C5aR 
antagonist (3D53), which binds specifically to C5aR (Finch AM et al. 1999, Monk PN et al. 
2007, Wong AK et al. 1998), was used to pre-treat 3T3-L1 adipocytes for 30 min prior to 
addition of the treatments.  
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2.6. Akt/NFκB/ERK Phosphorylation  
Total and phosphorylated Akt (Ser
473
), ERK (Thr
202/204-185/187
), and NFκB (Ser536) were 
quantified directly in lysed cells using ELISA-based assays, as previously published (Poursharifi 
P et al. 2013, Tom FQ et al. 2013). This methodology allows direct evaluation of both 
phosphorylated and total forms of the proteins simultaneously, reducing the technical 
manipulations of protein extraction, homogenization, and gel separation used in traditional 
western blot analysis. 
Akt and NFκB activation were measured in 3T3-L1 adipocytes by Fast Activated Cell-
based ELISA kit (Active Motif, Carlsbad, CA) as described by the manufacturer. Briefly, cells 
seeded in 96-well plates were stimulated with ASP (200 nM) and/or C5a (20 nM) for the 
indicated incubation times, and fixed with 4% formaldehyde. Following washing and blocking 
steps, cells were incubated overnight with anti-phospho or anti-total Akt and NFκB. Following 
incubation with anti-HRP conjugated IgG for 1 h at room temperature, a colorimetric assay was 
performed and absorbance at 450 nm was determined. The values were subsequently corrected 
for cell number using the absorbance values at 595 nm determined by crystal violet cell staining.  
Akt, ERK, and NFκB phosphorylation in primary adipocytes were analyzed by 
InstantOne ELISA kits purchased from eBioscience (San Diego, CA), following the 
manufacturer's protocol for non-adherent cells. In summary, freshly isolated primary adipocytes 
were seeded in 96 well plates (20,000 cells/well), treated for stimulation, then lysed and 
incubated with antibodies against phospho- and total-Akt/ERK/NFκB overnight and following 
colorimetric processing, absorbance readings were obtained at 450 nm/650 nm.  
2.7. Hormone Measurements  
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MCP-1 and KC concentrations were measured using mouse ELISA kits (R&D Systems, 
Minneapolis, MN) as per the manufacturer's instructions. Differentiated 3T3-L1 adipocytes and 
freshly isolated primary adipocytes (100,000 cells/1 mL) were incubated overnight (24 h) in SF 
media with the indicated treatment concentrations, and the media was then collected. All samples 
were assayed in triplicate. Following colorimetric processing (according to the instruction), 
optical density was determined by a microplate reader set to 450 nm with the wavelength 
correction set to 540 nm.  
2.8. RNA Extraction and qPCR Analysis  
RNA was extracted from the whole gonadal fat pad of C5aRKO and WT mice (RNeasy 
Plus Universal Mini Kit) and cDNA was synthesized using RT
2
 First Strand kit (Qiagen Inc., 
Mississauga, ON, Canada). mRNA expression level of each gene was quantified by CFX96
TM
 
Real-Time PCR Detection System (Bio-Rad Laboratories, Mississauga, ON, Canada). Primers 
were designed using the Mouse qPrimerDepot resource site (mouseprimerdepot.nci.nih.gov) and 
were purchased from Alpha-DNA (Montreal, Canada). Results were analyzed by the ΔΔCt 
relative quantification method and normalized to Eef2 As housekeeping gene. Primer sequences 
were as follows: mouse IRS1, forward 5'-CTATGCCAGCATCAGCTTCC-3' and reverse 5'-
GGAGGATTTGCTGAGGTCAT-3'; mouse PGC1α, forward 5'-
TGTAGCGACCAATCGGAAAT-3' and reverse 5'-TGAGGACCGCTAGCAAGTTT-3'; mouse 
Eef2, forward 5'- GCTTCCCTGTTCACCTCTGA-3' and reverse 5'- 
CGGATGTTGGCTTTCTTGTC-3'.  
2.9. Statistical Analysis  
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All values are presented as mean ± standard error of the mean (SEM), with 5-9 mice per 
group, or multiple wells from cell experiments (as indicated). Groups were compared using 
GraphPad Prism 5 (GraphPad Software, Inc., San Diego, CA) by two-way analysis of variance 
(ANOVA) followed by Bonferroni post-test, or by Student's t test, as indicated. Statistical 
significance was indicated as follows: *P < 0.05, **P < 0.01, ***P < 0.001. 
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3. Results 
3.1. C5aR is Required for C5a Metabolic, Immune and Signaling in Adipocytes  
As C5a has been shown to interact with both C5aR and C5L2, receptors involved in 
immune and lipid storage functions, the effects of C5a on MCP-1 and KC production, 
triglyceride synthesis (TGS), as well as Akt, ERK and NFκB signaling pathways were evaluated. 
MCP-1 and KC secretion increased significantly in WT adipocytes treated with 20 nM C5a 
(P < 0.001) (Fig 1A and B). In adipocytes from C5aRKO mice, the majority of C5a stimulation 
was lost (P < 0.001, WT+C5a vs C5aRKO+C5a), although there still remained a small 
significant C5a effect as compared to basal level (Fig 1A and B). C5a also increased TG storage, 
an important adipocyte function, in WT adipocytes (P < 0.001) (Fig 1C). By contrast, there was 
no stimulatory effect of C5a on TGS in C5aRKO adipocytes (Fig 1C). As shown in Figure 1D, in 
adipocytes from WT, C5a induced rapid phosphorylation of Akt on Ser
473
 by 5 min, reaching a 
peak at 30 min. In the absence of C5aR, C5a failed to induce Akt phosphorylation (two-way 
ANOVA, WT vs C5aRKO, P=0.0052).  There was no C5a activation of NFκB phosphorylation 
(Ser
536
) in adipocytes from either WT or C5aRKO (Fig 1E). While there was a small stimulation 
of C5a on ERK phosphorylation (Thr
202/204-185/187
) in WT adipocytes (Figure 1F), interestingly, 
the C5a impact on ERK phosphorylation increased in C5aRKO adipocytes (two-way ANOVA, 
WT vs C5aRKO, P<0.0001).  
3.2. C5a Impaired ASP Activity in WT and C5aRKO
 
Primary Adipocytes  
ASP is known (i) to stimulate triglyceride synthesis through C5L2 interaction (Cui W et 
al. 2007, Kalant D et al. 2005),  (ii) to increase MCP1 and KC secretion in adipocytes (Tom FQ 
et al. 2013), and also (iii) to enhance colocalization of C5aR with C5L2 in adipocytes and 
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macrophages (Poursharifi P et al. 2013). Based on this, the dual effect of ASP and C5a combined 
actions were evaluated together. Consistent with previous results, ASP alone strongly induced 
MCP-1 and KC production, as well as TGS in WT adipocytes (Fig 2A-C). In WT adipocytes, 
although addition of C5a had no effect on ASP stimulation of TGS, C5a reduced the ASP effect 
on MCP-1 and KC (although still remaining significant). By contrast, in C5arKO adipocytes, 
ASP effects on MCP-1 secretion and TGS were comparable, but were reduced for KC secretion 
although still remaining significant (P<0.0001).  However addition of C5a completely blocked 
all functional effects of ASP in C5aRKO adipocytes, with responses decreased to basal levels 
(Fig 2A-C). 
3.3. C5a Blocked ASP Signaling Pathways in C5aRKO and WT Primary Adipocytes  
Based on the C5a interference with ASP functionality, signaling pathways were further 
assessed to determine the mechanism of negative C5a feedback. As shown in Figure 3A, while 
ASP stimulated time-dependent Akt (Ser
473
) phosphorylation in WT adipocytes, addition of C5a 
partially blocked the ASP effect.  Similarly, ASP stimulation of NFκB (Ser536) phosphorylation 
in WT adipocytes was blocked by addition of C5a (Fig 3D). By contrast, in C5aRKO adipocytes, 
there was little effect of either ASP or ASP+C5a (Figs 3B and E), as with the lack of C5a 
response (Figure 3C and F). ERK activation followed a different profile: while there was no 
significant change in phospho-ERK relative to total ERK between ASP treated versus ASP+C5a 
stimulated adipocytes (Fig 3G and H), adipocytes from C5aRKO mice were more responsive 
than WT, regardless of the ligand stimulation (ASP, ASP+C5a or C5a, Figure 3I).  
3.4. C5a Interferes with ASP Function and Signaling in 3T3-L1 Adipocytes  
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Similar experiments were also conducted in 3T3-L1 adipocytes to confirm the results 
obtained from primary adipocytes. As shown in Figure 4 A-D, C5a and ASP both independently 
increased MCP-1 and KC secretion as well as Akt and NFκB phosphorylation. However, 
treatment of 3T3-L1 adipocytes simultaneously with ASP and C5a significantly diminished the 
ASP effects on MCP-1 and KC secretion as well as on Akt and NFκB phosphorylation. 
Interestingly, treating the cells with the combination of ASP and 3D53, a specific C5aR 
antagonist that does not bind either C5L2 or C3aR (Lim et al., 2013), blocked the ASP effect, 
decreasing TGS to basal levels (Fig 4E and F).   
3.5. C5aR Disruption Induced Partial Insulin Resistance in Primary Adipocytes  
As demonstrated above the presence of C5aR influenced most adipocyte immune and 
metabolic responses; this suggested a potential involvement of C5aR receptors in insulin 
resistance. To address this possibility, adipocytes from WT and C5aRKO
 
mice were assessed for 
insulin effects on cytokine production, TGS, signaling pathways, and gene expression. As shown 
in Figure 5, insulin stimulated MCP-1 and KC secretion (Fig 5A and B), TGS (5C), and Akt, 
NFκB, and ERK phosphorylation (Fig 5D-F) in WT adipocytes. Interestingly, C5aRKO 
adipocytes revealed impaired insulin stimulation of MCP-1 and KC production (Fig 5A, B) and 
NFκB phosphorylation on Ser536 (Fig 5E) with partial impairment of TGS (Fig 5C) and Akt 
phosphorylation (Ser
473
) (Fig 5D). Of relevance, mRNA expression of IRS1 and PGC1α was 
lower in adipose tissue from C5aRKO (Fig 5G).  By contrast, as shown in Figure 5F, there was 
an increase of insulin-stimulated ERK phosphorylation (Thr
202/204-185/187
) in C5aRKO mice in 
comparison to WT (two-way ANOVA, P=0.04). 
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4. Discussion 
The present study extends previous findings for C5aR and C5L2 interaction, by 
proposing new insights into the C5a-C5aR role in adipocyte metabolism and immunity, and 
demonstrating regulatory impact on ASP and insulin-mediated functions. The close physical 
interaction of C5aR and C5L2 has been recently demonstrated in several studies, with 
heterodimerization of C5aR and C5L2 in transfected cells (Poursharifi P et al. 2013), 
colocalization of internalized C5aR with both C5L2 and β-arrestin in neutrophils (Bamberg CE 
et al. 2010), and internalization/colocalization of C5aR and C5L2 in C5a- or ASP-stimulated 
macrophages and adipocytes (Poursharifi P et al. 2013). Although there are only a few studies 
using C5aR and/or C5L2 antibodies/antagonists or knockout models, the results are consistent 
with coupled immune-metabolic aspects in adipocytes (Cui W et al. 2007, Lim J et al. 2013). 
However, the individual contributions of C5aR and C5L2 to adipose tissue functions and 
signaling are not yet clear. Lim et al. demonstrated C5a effects on lipid and glucose metabolism 
in adipocytes by using a C5aR-selective antagonist which interfered with C5a-mediated fatty 
acid uptake (Lim J et al. 2013). In the present study, where the potential cross-talk between 
C5aR and C5L2 in adipocytes was evaluated, the use of C5aRKO models allowed us to 
investigate (i) C5a-C5L2 function and signaling, (ii) C5a effects on ASP function and signaling, 
and (iii) the potential role of C5aR in insulin sensitivity in adipocytes.   
C5a, a potent mediator of inflammation, has also been shown to be associated with 
adipocyte metabolism, by influencing lipogenesis, glucose uptake, and lipolysis (Lim J et al. 
2013). These insulin-like effects in adipocytes have previously been well-established for ASP 
(Cianflone KM et al. 1989, Kalant D et al. 2005). Moreover, Akt and ERK have been shown to 
be involved in insulin- and ASP-mediated TGS lipid storage pathways in 3T3-L1 preadipocytes 
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(Maslowska M et al. 2006). Additionally, in vitro studies by Tom et al. suggested that ASP-
mediated stimulation of the inflammatory factors, MCP-1 and KC, involved both NFκB and Akt 
mediated pathways (Tom FQ et al. 2013). In accordance with our findings, both C5a and ASP 
independently enhanced adipocyte function and signaling, however the disruption of C5aR 
reduced the C5a effects on inflammatory cytokine secretion, TGS, and Akt phosphorylation, 
whereas ASP effects mostly remained intact. Collectively, we speculate that the responses to C5a 
in primary adipocytes are primarily mediated through C5aR, while ASP effects, in certain cases, 
were manifested only in the presence of both C5aR and C5L2 receptors, possibly as 
heterodimers. Accordingly, in vitro assays with 3T3-L1 adipocytes pre-treated with a C5aR 
antagonist showed significantly reduced ASP effects on TGS. Of note, C5aR does not seem to 
play a role in C5a or ASP activation of ERK, since ERK phosphorylation remained comparable 
or greater in C5aRKO adipocytes, possibly pointing to a role for C5L2 in this process. Of 
relevance, neutrophils and macrophages obtained from C5L2KO mice showed absence of ERK 
phosphorylation following C3a stimulation, in contrast to the WT mice (Chen NJ et al. 2007).  
This study has shown that C5a interfered with ASP functions and signaling in primary 
adipocytes and that the effects were more pronounced in C5aRKO adipocytes. In like manner, 
combination of C5a and ASP stimulation on 3T3-L1 adipocytes, negatively influenced ASP 
impact on cytokine secretion and signaling. Since ASP and C5a do not appear to compete for the 
same binding sites on C5L2 (Kalant D et al. 2003), then the C5a negative influence on ASP 
action could support the hypothesis that ASP does indeed bind to C5L2. This contrasts with the 
interpretation of other studies (Johswich K et al. 2006, Johswich K and Klos A 2007) reporting 
no such binding, but those studies were based solely on lack of competitive radioligand 
displacement with labelled C5a. If so, this would be consistent with C5a-C5aR/C5L2 exerting 
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regulatory effects via ASP-C5L2 pathway in adipocytes. This type of ligand-receptor blocking 
has been demonstrated elsewhere. For example, in an analogous fashion, a study by Pello et al. 
indicated that the simultaneous stimulation of CXCR4- and δ-opioid receptor (DOR)-expressing 
cells blocked the individual responses of the receptors. It was proposed that formation of 
CXCR4/DOR heterodimers, as a silent signaling complex, resulted following exposure to the 
combination of ligands (Pello OM et al. 2008).  
Studies with C5L2KO mice have demonstrated a pathophysiological role for C5L2 in 
insulin resistance, lipid metabolism and sepsis (Fisette A et al. 2013, Gao H et al. 2005, Gerard 
NP et al. 2005, Paglialunga S et al. 2007). Further, it is suggested that disruption of an ASP-
C5L2 dependent signaling pathway may contribute to altered energy metabolism (Cianflone K et 
al. 2003) and induce beneficial effects (Paglialunga S et al. 2007, Roy C et al. 2008). By 
contrast, the absence of C5L2 has been shown to accentuate insulin resistance induced by a high-
fat-high-sucrose diet (Fisette A et al. 2013). Further, recent in vivo studies with C5aR and C3aR 
selective inhibitors revealed an improved inflammatory profile, suggesting specific roles for 
C5aR and C3aR in metabolic dysfunction such as obesity (Lim J et al. 2013). Based on our 
current results, in the absence of C5aR, adipocytes appear to lose the pro-inflammatory effects of 
insulin on MCP-1 and KC production, and NFκB phosphorylation, while maintaining ERK 
activation along with a trend towards lower expression of genes responsible for metabolic 
disorders, including insulin resistance (IRS1 and PGC1α). Interestingly, survival in high-grade 
(100% lethality) sepsis required simultaneous blockade of C5aR and C5L2 receptors (Rittirsch D 
et al. 2008). Thus, synergic pro-inflammatory contributions of C5aR and C5L2 in sepsis might 
reflect an adaptive C5L2 mechanism in response to chronic levels of C5a.  
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5. Conclusion 
In conclusion, these novel findings provide evidence that C5a may function as a negative 
regulator of ASP, which acts via both C5aR and C5L2. Together, these findings reveal that C5aR 
is associated with multiple inflammatory mechanisms in adipocytes, which could be regulated by 
heterodimerization with C5L2, in a ligand dependent manner. Preclinical/clinical trials have been 
undertaken to target C5a-C5aR interaction, following development of compounds acting on 
either C5 (to prevent its cleavage), or on C5aR (to prevent activation by C5a). The chronic 
antagonism of C5aR may adversely affect host defence and other beneficial complement 
functions, however this has recently been addressed by developing alternative tissue specific 
antibody therapies (Durigutto P et al. 2013).  Given the potential therapeutic value of inhibiting 
C5a-C5aR function to prevent or slow progression of inflammation (Monk PN et al. 2007), 
further studies are essential to better understand how C5a-C5aR/C5L2 alternative pathways 
adjust to different pathophysiological environments, and might have unexpected influences on 
adipose tissue. 
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10. Figure Legends 
Figure 1. C5aR is Required for C5a Metabolic, Immune and Signaling in Adipocytes. 
Mouse adipose tissue from WT and C5aRKO mice was dissected, and primary adipocytes were 
prepared by collagenase digestion. A and B: Mature adipocytes were treated with C5a for 24 h, 
then MCP-1 and KC secretion were evaluated in cell culture medium. C, Primary adipocytes 
were treated with C5a for 1 h, then uptake and incorporation of fluorescently-labeled fatty acid 
into lipids was measured. D to F: Freshly isolated adipocytes were seeded in 96 well plates 
(20,000 cells/well) and were treated with C5a (T=0, 15, 30, 45 min) at 37°C, then Akt (D), NFκB 
(E), and ERK (F) phosphorylation and total protein were analyzed. Values are means ± SEM; 
white bars represent baseline with only PBS and striped bars represent C5a (20 nM). Significant 
differences were analyzed by t-test or two-way ANOVA: *P < 0.05, **P < 0.01, ***P < 0.001 
vs. BSL. 
Figure 2. C5a Impaired ASP Activity in WT and C5aRKO
 
Primary Adipocytes. A and B, 
Mouse gonadal adipose tissue obtained from WT and C5aRKO mice was dissected, and primary 
adipocytes were prepared by collagenase digestion. Mature adipocytes were treated with ASP 
and ASP+C5a for 24 h, then MCP-1 and KC secretion were evaluated in cell culture medium. C, 
Primary adipocytes were treated with ASP and ASP+C5a for 1 h then uptake and incorporation 
of fluorescently-labeled fatty acid into lipids was measured.  Values are means ± SEM, where 
white bars represent baseline with only PBS (BSL), striped bars represent ASP (200 nM), and 
checkered bars represent ASP (200 nM) + C5a (20 nM). Significant differences were analyzed 
by t-test: **P < 0.01, ***P < 0.001 vs. BSL. 
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Figure 3. C5a Blocked ASP Signaling Pathways in C5aRKO and WT Primary Adipocytes. 
Freshly isolated primary adipocytes from WT and C5aRKO mice were seeded in 96 well plates 
(20,000 cells/well) and were treated with ASP (200 nM) or the combination of ASP (200 nM) 
and C5a (20 nM) for 15, 30, and 45 min at 37°C, then Akt (A and B), NFκB (D and E), and ERK 
(G and H) phosphorylation and total protein were analyzed. The ratio of phosphorylation/total 
(%) area under the curve (AUC) for Akt (C), NFκB (F), and ERK (I) in WT and C5aRKO 
adipocytes are presented. Treatments: C5a (white bars), ASP (striped bars), and ASP+C5a 
(checkered bars). Values are presented as means ± SEM. Significant differences were analyzed 
by t-test or two-way ANOVA: *P < 0.05, **P < 0.01 vs. BSL. 
Figure 4. C5a Interferes with ASP Function and Signaling in 3T3-L1 Adipocytes. 3T3-L1 
adipocytes were differentiated and then incubated in serum-free media 2 h prior to treatments. 
Treatments: PBS (BSL), insulin (INS; 100 nM), ASP (200 nM), and C5a (20 nM). A and B, 3T3-
L1 adipocytes were treated with C5a (20 nM) and/or ASP (200 nM) for 24 h, then MCP-1 and 
KC secretion were evaluated in cell culture medium. 3T3-L1 adipocytes were treated with either 
ASP (200 nM, T=0, 15, 30, 45 min) and/or C5a (20 nM, T=0, 15, 30, 60, 90) at 37°C, then Akt 
(C) and NFκB (D) phosphorylation and total protein were measured. E, 3T3-L1 adipocytes were 
pre-treated with C5aR antagonist (3D53; 1 μM) for 30 min prior to addition of the treatments. 
Cells were incubated with the treatments for 1 h at 37 °C. Uptake and incorporation of 
fluorescently-labeled fatty acid into lipids was measured over 115 min. F, Results are presented 
for fatty acid uptake area-under-the-curve (AUC). Values are means ± SEM. Significant 
differences were analyzed by t-test or two-way ANOVA: *P < 0.05, **P < 0.01, ***P < 0.001 
vs. BSL. 
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Figure 5. C5aR Disruption Induced Partial Insulin Resistance in Primary Adipocytes. A 
and B, Mouse gonadal adipose tissue from WT and C5aRKO mice was dissected, and primary 
adipocytes were prepared by collagenase digestion. Mature adipocytes were treated with insulin 
for 24 h, and then MCP-1 and KC secretion were evaluated in cell culture medium. White bars 
represent baseline with only PBS treatment and striped bars represent insulin (100 nM) 
treatment. Freshly isolated primary adipocytes were seeded in 96 well plates (20,000 cells/well) 
and were treated with insulin for 15, 30, and 45 min at 37°C, then analyzed for Akt (D), NFκB 
(E), and ERK (F) phosphorylation and total protein. G, IRS1 (insulin receptor substrate 1) and 
PGC1α (peroxisome proliferator-activated receptor-γ co-activator 1-α) gene expression was 
evaluated in adipose tissue obtained from WT (striped bars) and C5aRKO (white bars) mice by 
RT-quantitative PCR, expressed relative to the housekeeping gene Eef2 (eukaryotic elongation 
factor 2). Values are presented as means ± SEM; n = 5-9 per group. Significant differences were 
analyzed by t-test or two-way ANOVA: *P < 0.05, **P < 0.01, ***P < 0.001 vs. BSL. 
HIGHLIGHTS:  
 
 ASP and C5a increase MCP1, KC and TGS via Akt/NFκB pathways in adipocytes. 
 
 C5a effects are absent in C5aRKO adipocytes, while ASP effects are mostly 
maintained. 
 
 C5a blocks ASP signaling in C5aRKO and WT adipocytes, and 3T3-L1 adipocytes. 
 
 C5aR is implicated in immunity and metabolism in adipose tissue. 
 
 C5aR may mediate effects via C5L2 heterodimerization. 
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